Responses
Basic tumor immunology
Original research
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
